Degradation of deoxyribonucleic acid by metal complexes of daunomycin, 1985 by Glover, Gwendolyn P. (Author) & Habte Mariam, Yitbarek (Degree supervisor)
DEGRADATION OF DEOXYRIBONUCLEIC ACID BY METAL COMPLEXES 
OF DAUNOMYCIN 
A THESIS 
SUBMITTED TO THE FACULTY OF ATLANTA UNIVERSITY 
IN PARTIAL FULFILLMENT OF THE REQUIREMENTS FOR 
THE DEGREE OF MASTER OF SCIENCE 
BY 
GWENDOLYN PATRICE GLOVER 
DEPARTMENT OF CHEMISTRY 
ATLANTA, GEORGIA 
MAY 1985 
ÇLi V 11 J - 
brought to you by COREView metadata, citation and similar papers at core.ac.uk
provided by DigitalCommons@Robert W. Woodruff Library
ABSTRACT 
CHEMISTRY 
GLOVER, GWENDOLYN PATRICE B.S. Xavier University, 1982 
DEGRADATION OF DEOXYRIBONUCLEIC ACID BY METAL COMPLEXES OF DAUNOMYCIN 
Advisor: Professor Yitbarek Habte-Mariam 
Thesis dated May 1985 
The effects of metal complexes of daunomycin on DNA degradation 
have been studied. Daunomycin, in the presence of a reducing agent, 
Cu(II), and molecular oxygen, causes degradation of double-stranded DNA 
to acid-soluble product. Other metal ions such as Zn(II), Mg(11 ), 
Fe(II), Fe(III), Ca(II), and Yb(III) were also effective in degrading 
DNA. The reducing agent requirement of the degradation can be met by a 
free-radical generating system, such as hypoxanthine-xanthine oxidase. 
The degradation was inhibited by catalase, indicating hydrogen peroxide 
as an important intermediate in the degradation. The reaction proceeds 
in two stages: (1) reduction of oxygen leading to hydrogen peroxide, 
and (2) peroxide-dependent DNA cleavage. The hydroxyl radical scaven¬ 
gers, benzoate and acetate, caused only partial inhibition suggesting 
that other reactive species may be responsible for degradation. 
The effective inhibition of the degradation by ethidium bromide 
and absolute preference for double-stranded DNA as a substrate indicat¬ 
ed the degradation proceeded via intercalation. A possible mechanism 
is proposed for the degradation of DNA by daunomycin-metal complex. 
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INTRODUCTION 
Deoxyribonucleic acid (DNA), the genetic material in living cells, 
can interact with a certain class of powerful drugs, which possess ex¬ 
tended (hetero)-cyclic aromatic chromophores. Owing to DNA's control¬ 
ling role in DNA replication and protein biosynthesis, modification by 
such interactions greatly alters cell metabolism by diminishing, and 
in some cases, by terminating cell growth.1 These drugs are used in 
the treatment of human diseases and are referred to as chemotherapeutic 
agents, although those produced by microorganisms are more specifically 
called antibiotics. 
Daunomycin, a glycosidic anthracycline antibiotic, belongs to the 
group of antibiotics called rhodomycin and is isolated from fermenta¬ 
tion broths of Streptomyces peucetius. Daunomycin is among the first 
of the most promising antitumor agents developed for the clinical 
treatment of acute leukemia, breast cancer, Hodgkin's diseases and 
sarcomas.^ It has an aglycone chromophore containing four fused rings 
and an amino sugar (Figure 1). Daunomycin has been the subject of in¬ 
tensive chemical and biological research since its discovery 17 years 
ago. Its strong DNA binding properties led the discoverers of the 
antibiotic to suggest that the drug receptor site was DNA.3 The clini¬ 
cal use of daunomycin has made its mode of interaction with DNA a mat¬ 
ter of considerable interest. 
There are two models that describe the interaction of various 
planar, aromatic drugs with deoxyribonucleic acid. One of these 
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Figure 1. Structure of daunomycin. 
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modes of binding is the interaction with DNA by means of external 
binding (Figure 2). These substances bind in one of the grooves of 
DNA and if cationic, the binding is enhanced due to interactions of 
the cationic moieties of the ligands with the DNA phosphates. Binding 
of this type typically causes little conformational change in the DNA 
molecule and does not lead to the extension and unwinding of the dou¬ 
ble helix. The other mode of interaction is internal binding of the 
drug molecule by an intercalative mode (Figure 2). The intercalation 
model was originally proposed by Lerman for the binding of acridine 
dyes.^ Lerman substantiated this hypothesis by a wide range of hy¬ 
drodynamic, optical, and chemical evidence.6 In general, the bind¬ 
ing of the drugs to DNA stabilizes the double stranded DNA structure, 
as manifested by an increase in the melting temperature of the double 
stranded DNA.6 The increased viscosity and the decreased sediment¬ 
ation coefficient indicate that the DNA molecule becomes longer, 
thinner, and stiffer.6 This was also shown by light scattering 
and low angle X-ray scattering, which indicated a reduced mass per 
unit length. These observations were also confirmed by electron 
microscopy and autoradiography, which indicated an increased DNA 
contour length.6 The X-ray diffraction patterns obtained by investi¬ 
gators from the drug-DNA fibres showed that DNA retained its regular 
double helical structure.6 
According to Lerman,6 planar drugs insert themselves between two 
successive base pairs that are 3.4Â apart. The hydrophobic portion 
of the drug molecule is stabilized in its intercalated mode, away from 




the aqueous environment, by stacking interactions resulting from the 
extensive overlap of the TT electron clouds of the chromophore and the 
nucleic bases. However, because the distance between base pairs must 
increase to accommodate the intercalated molecule, the sugar phosphate 
backbone is fully extended and the original helical structure is per¬ 
turbed (Figure 2). 
To refine Lerman's original model ,5 Fuller and Waring7 examined 
the interaction of ethidium bromide and DNA. Using X-ray diffraction 
studies, they suggested that the intercalated mode could also be stabi¬ 
lized by specific hydrogen bonding between the amino groups at two 
extremities of the drug chromophore and the phosphate groups on the DNA 
backbone chains. Subsequently, employing the hydroxyquinone moiety of 
daunomycin and the electrostatic interaction involving the protonated 
amino group on daunosamine, investigators were able to explain the 
intercalative process of the anthracycline antibiotics binding.® 
The mechanism by which daunomycin exhibits its antineoplastic ac¬ 
tivity cannot, however, be totally explained by intercalation, since 
other intercalating agents do not have the same chemotherapeutic ac¬ 
tivities. For a number of intercalating agents no obvious relation¬ 
ship emerges between their abilities to inhibit nucleic acid synthesis, 
as well as their cytotoxic effects, and their modes of binding.9 There¬ 
fore, one is inclined to consider other modes of action of these an¬ 
thracycline antibiotics that make their chemotherapeutic activities 
different. 
After the administration of daunomycin, the drug enters the cell, 
and once inside, daunomycin localizes in the nucleus and is believed 
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to act by inhibiting both DNA replication and RNA transcription.111 
Because metal ions are present in all biological processes involving 
the nucleic acid and since DNA seems to be the receptor site for dauno- 
mycin action,1 the occurrence of daunomycin-metal ion complexes inside 
the cell may play an important step in the course of its antineoplas¬ 
tic activity. If this is so, a better understanding of the effects 
of metal ion complexes of the anthracyclines may provide more insight 
into the mode of action of the anthracyclines. 
Several recent observations have focused attention on the degra¬ 
dation of DNA by metal-1,10-phenanthroline complexes.11The metal 
chelator 1,10-phenanthroline has been reported to inhibit virtually 
all nucleotidyl transferases (DNA polymerase, RNA polymerase, reverse 
transcriptase, and terminal transferase).^ Many of these nucleotidyl 
transferases have been found to contain zinc, and it has been demon¬ 
strated that zinc plays a functional role in nucleotide polymeri¬ 
zation.^»^ -js believed that the inhibitory effect of 1,10-phenanth¬ 
rol ine may be a result of either the removal of zinc from the enzyme or 
the formation of a complex between the metal chelator and the enzyme- 
bound zinc.Although anthracycline antibiotics are strong metal 
chelators,16 like 1,10-phenanthroline,^ it is not known if their 
mode of action is due to their transformed products, or due to their 
chelation to metal ions such as zinc and magnesium. These two possible 
modes of action have not been throughly investigated. It was, there¬ 
fore, deemed neccessary to analyze the effects of physiological levels 
of relevant divalent metals (e.g., Zn(II), Mg(II), Ca(II), etc.), com- 
plexed with daunomycin, on the degradation of DNA. 
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The degradation of DNA may involve yet another mode of action of 
these anthracyclines, i.e., a free radical mechanism. Degradation by 
this mechanism occurs after drugs, such as bleomycin, mitomycins B and 
C have undergone a reductive cycle in which electrons are transferred 
to oxygen, resulting in the formation of oxygen radicals.1^ Clinical 
use of these drugs are limited because of their toxic side effects, 
which may be attributed to the lethal production of free radicals in 
the cell. Although the mechanisms leading to cardiotoxicity are not 
fully understood, evidence strongly points to oxygen radical damage. 
There is a structural similarity between the quinone moiety of 
the anthracyclines and that of the antineoplastic agents streptonigrin, 
mitomycins B and C and certain 5,8-quinolinediones, which have been 
shown to cleave DNA after reduction by a common free radical mecha¬ 
nism. 18,20 since the chromophore of the anthracyclines is known 
to be reduced during their metabolism,21>22 we believe metal ions may 
facilitate the reduction of daunomycin. Metal complexes may be benefi¬ 
cial in determining the probable reactive intermediates, such as super- 
oxide anion, hydrogen peroxide, and hydroxyl radicals, of the reaction, 
as well as in giving insight into the mechanism of cardiotoxicity. 
The cationic dye ethidium has been used in a wide variety of 
spectroscopic techniques in biochemical and physical studies of nu¬ 
cleic acids.23 Ethidium interacts with double-stranded DNA and 
RNA by intercalating between adjacent alternating purine-pyrimidine 
base pairs. The intercalative property of ethidium makes it a 
useful probe in measuring changes in the DNA or RNA active sites 
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available during the binding of other drug species. Analysis of its 
effects on the degradation of DNA by daunomycin was thought to be 
useful in determining the role of intercalation in the degradation 
reaction. The interactions of daunomycin with double stranded and 
heat denatured poly (dA-T) were also compared to assess the depen¬ 
dence of the degradation of DNA by daunomycin on DNA secondary struc¬ 
ture. We believe this approach will provide information about the 
modes of action of a variety of other structurally similar antibiot¬ 
ics. 
The purpose of this work was, therefore, to determine the ability 
of metal complexes of daunomycin to degrade DNA, and to examine the 
applicability of the proposed mechanism of degradation of DNA by the 
l,10-phenanthroline-Cu(II) complex to that by daunomycin-metal 
complexes.^ The 1,10-phenanthroline-Cu(II) system had been suggested 
to be a simple model system for studying the mechanism of action of a 
variety of structurally more complex antibiotics.12 in this thesis, 
the similarities and differences of the 1,10-phenanthroline and the 
daunomycin-metal complexes will be discussed. Based on the work 
done, an attempt will be made to develop a possible mechanism, 
different from that proposed for 1,10-phenanthroline-Cu(11 ), for the 
in vitro degradation of DNA by daunomycin. 
EXPERIMENTAL 
Materials 
Double-stranded polydeoxyadenylic-thymidylic acid [poly(dA-T)], 
2‘-deoxyadenosine 5'-tri phosphate (dATP), thymidine 5'-triphosphate 
(TTP), 2-mercaptoethanol , benzoic acid, sodium acetate, cytochrome C, 
ethidium bromide, hypoxanthine, Hepes, xanthine, xanthine oxidase 
(0.5 units/mg), catalase (5000 units/mg), superoxide dismutase (3000 
units/mg), and purified daunomycin were purchased from Sigma Chemical 
Co. Concentrations of DNA and daunomycin were determined spectro- 
photometrically using £259 = 6600 M cm and e^gg =11,500 M cm , 
respectively. As daunomycin solutions are sensitive to light and air, 
stock solutions were prepared fresh each day. [Methyl-^H] thymidine 
5'-triphosphate, tetrasodium salt (0.0070 mg/ml, specific activity 
81.5 Ci/mmole) was purchased from Schwarz/Mann and E_. coli DNA poly¬ 
merase I from Bethesda Research Laboratories, Inc. Chelex 100, minus 
400 mesh, a chelating ion resin, was purchased from Bio-Rad Labora¬ 
tories. Hydrogen peroxide, sodium chloride, CUSO4, ZnCl2» MgCl2« 
FeCl2, EeCl3, CaCl2, and YbClgwere all obtained from Fisher Chemical, 
Co. 
All uv and visible spectrophotometric measurements were made 




Preparation of -^-labeled Deoxyribonucleotide 
Double stranded poly(dA-[3H]T) was prepared by using 4 units of 
E_. coli DNA polymerase I in a polymerization reaction primed with 
unlabeled double stranded poly(dA-T). The preparation is a modifi¬ 
cation of the method of Modrich and Lehman.24 in addition to the 
enzyme, the reaction mixture contained unlabeled polymer (39 nmol/ml) 
in an incubation mixture containing 50 mM potassium phosphate, pH 
7.4, 6.7 mM magnesium chloride, 1 mM 2-mercaptoethanol, 33 pM 
2'-deoxyadenosine 5'-triphosphate, 33 pM thymidine 5'-triphosphate, 
and [methyl-^H] thymidine 51-triphosphate. The incubation mixture 
was equilibrated at 37°C prior to the addition of DNA polymerase I 
and then incubated for 30 min at 37°C. The reaction can be monitored 
by determining the amount of tritium incorporated in an acid-precipi- 
table product (see below). When no further significant increase in 
incorporation was observed, the enzyme was inactivated by adding 2 ml 
of 0.4 M sodium chloride to the incubation mixture. The mixture was 
then heated to 75°C for 15 min, and rapidly chilled in an ice water 
bath to enhance intermolecular helix formation. Unincorporated 
nucleotides were removed by dialysis and finally by dialysis against 
deionized distilled water. The product was concentrated in an Amicon 
Stirred Ultrafiltration Cell, or in some cases, the sample was concen¬ 
trated three-fold by dialysis against solid polyethylene glycol 
(carbowax 6000) followed by dialysis against deionized water. 
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The incorporation of tritium in an acid-precipitable product was 
analyzed in the following manner. At five-min intervals, 25 yl 
of the incubation mixture was added to a chilled mixture of four 
parts saturated sodium phosphate, four parts saturated sodium pyro¬ 
phosphate, one part 10% trichloroacetic acid, and one part 10 mM 
thymidine, vortexed, and incubated in an ice water bath (0-4°C) for 15 
minutes. The acid-precipitable product was then collected by fiber 
filter (Whatman GFC, 2.4 cm) and washed five times with 5 ml of 10% 
trichloroacetic acid. The filtrate was placed in a glass liquid 
scintillation vial with 10 ml of Biofluor, a high efficiency emulsi¬ 
fier cocktail. 
Regeneration and Conversion of Chelex 100 Chelating Ion Exchange Resin 
Chelex 100, the styrene divinyl benzene copolymer, which con¬ 
tains paired iminodiacetate ions, possesses chelating groups for the 
binding of metal ions. Distilled water and all solutions other than 
those of metal salts were Chelex-treated to scavenge metal contami¬ 
nants with a high degree of purity without altering the concen¬ 
tration of the non-metallic ions. 
The technique of using Chelex 100 closely paralleled the tech¬ 
nique employed by Samuelson.25 The preparation requires regeneration 
and conversion of the resin. 
Regeneration to a salt form is a two step process. Chelex 100 
was first converted to the hydrogen form using an acid. The resin 
was then suspended in two bed volumes of water. Chelex 100 in the 
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hydrogen form has a pH of 2-3. The resin was finally converted to 
the desired ionic form using the hydroxide of the cation desired. 
The regeneration to the sodium form was accomplished by resuspending 
the resin in two bed volumes of water. The pH in the sodium form was 
about 11, and might be slowly lowered by extensive washing with water. 
However, a more satisfactory procedure for adjusting the pH is to 
use a buffer which has a buffering capacity closest to the solution 
being treated. 
The resin should be stored in a salt form such as that of sodium 
or ammonium. If left in the acid form for more than a few hours, the 
resin can be regenerated by heating at 60°C in 30-50% alkali for 
24 hours. Free iminodiacetic acid produced upon long standing (detect¬ 
ed by its odor) can be extracted with methanol, or removed by heating 
to 80°C in 3N ammonium hydroxide for two hours. 
Degradation of DNA by Daunomycin 
The procedure for the degradation of poly(dA-[3H]T), determined 
by acid solubilization, was the method used earlier by Downey et al.^ 
The reaction mixture contained, in a final volume of 0.1 ml, 50 vM 
daunomycin, 50 nti Hepes buffer, pH 7.4, 20 uM poly(dA-[^H]T), 1 mM 
2-mercaptoethanol and 2.5 uM CUSO4. After 30 min at 25°C, the 
reaction was stopped by the addition of 0.01 ml of 1 M EDTA, pH 8.0, 
0.1 ml of salmon sperm DNA, 2 mg/ml, and 0.5 ml 1 M perchloric acid. 
After 10 min at 0°C, the solution was centrifuged at 7,500 rpm for 10 
min and an aliquot of the supernatant was counted in 10 ml of Biofluor 
in a liquid scintillation counter. 
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Enzymatic Assay For Superoxide Dismutase 
The method employed was that of McCord and Fridovich^S and is 
based on the ability of superoxide dismutase to inhibit the reduction 
of cytochrome C. The reaction cocktail contained 0.216 M potassium 
phosphate, pH 7.8, 10.7 ntl EDTA, 1.1 mM cytochrome C, and 0.108 mM 
xanthine. Xanthine oxidase and superoxide dismutase solutions were 
prepared immediately before use by diluting to a final concentration 
of approximately 0.05 units per ml and 10 units per ml of ice cold 
water, respectively. The reaction cocktail (2.80 ml) was transferred 
to a quartz cuvette (1 cm path length). At zero time, 0.10 ml of 
xanthine oxidase was added and the increase in O.D. at 550 nm was 
monitored for 30 seconds. The change in the absorbance reading at 
550 nm was recorded every five min. Moreover, the addition of 
0.10 ml superoxide dismutase was monitored for 2 minutes at 550 nm 
and then recorded. The initial rate was calculated and fell within 
the given experimental range, indicating that the results were valid.26 
Enzymatic Assay For Catalase 
The method used was essentially that described by Beers and 
Sizer27 in which the disappearance of peroxide is followed spectropho- 
tometrically at 240 nm. The substrate solution contained 0.1 ml 
of 30% hydrogen peroxide in 50 ml of 0.05 M phosphate buffer, pH 7.0. 
The absorbance of the substrate solution, at 240 nm, was observed 
and fell within the range of 0.550 and 0.520 (which is the suggest¬ 
ed range for reproducible results). Immediately prior to use, the 
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enzyme was diluted in 0.05 M potassium phosphate buffer to a concen¬ 
tration of 5-20 units per ml. The addition of 0.1 ml of diluted 
enzyme was monitored during the time required for the absorbance at 
240 nm to decrease from 0.450 to 0.400 O.D. This corresponds to the 
decomposition of 3.45 ymole of H2O2 in a 3 ml solution. 
Enzymatic Assay For Xanthine Oxidase 
The assay of xanthine oxidase is a method taken from the Sigma 
catalog, in which xanthine oxidase catalyzes the conversion of xan¬ 
thine to uric acid. In two quartz cuvettes (1 cm path length), the 
following were pipeted: 0.05 M KH2PO4, pH 7.5 (both in the reference 
and the sample cuvettes) and 0.02 mg of xanthine (only in the refer¬ 
ence cuvette). The two cuvettes were allowed to equilibrate at 25°C 
for 10 min and 0.1 to 0.2 units/ml of xanthine oxidase was then added 
to both cuvettes. The contents of both cuvettes were manually mixed 
immediately, and placed in the spectrophotometer to record the in¬ 
crease in absorbance at 290 nm due to the formation of uric acid. 
The change at 290 nm per minute was recorded and the units per mg of 
enzyme were calculated. 
Difference Spectra Studies 
In the difference spectroscopy experiments, the reference and 
sample cuvettes contained solutions which were identical except for 
the order of addition of ethidium bromide. The concentrations of 
each component were diluted to 1/8 the concentration of the original 
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system in order to insure that the spectrum would be within the 
absorbance range of 0.05. The sample cuvette contained daunomycin and 
Cu(II) in Hepes, buffered at pH 7.4. After two min, poly (dA-T) was 
added. Ethidium bromide, daunomycin, and Cu(II) were placed in the 
reference cuvette at the same pH. Both cuvettes were allowed to 
equilibrate for 10 min, after which poly (dA-T) and ethidium bromide 
were added to the reference and sample cuvettes, respectively. Spec¬ 
tra were taken after 0, 10, 20, 30, and 40 min. 
Calculation of Percent Acid Soluble Product 
A control sample was prepared by placing an aliquot of a stock 
solution of poly (dA-[^H]T) in a tube and bringing the volume to 
0.750 ml. A 10 ul-aliquot of this final sample was then counted in 
10 ml of Bioflour to obtain the control counts per minute (cpmcon). 
The same volume of aliquot of the stock solution of poly (dA-[^H]T) 
was also added to the reaction mixture giving the same level of 
radioactivity in the control and the reaction mixture. After the 
reaction was stopped and the supernatant was obtained (vide supra), 
the volume of which was 0.75 ml, a 10 ul-aliquot of the super¬ 
natant was counted in 10 ml of Bioflour to obtain the experimental 
count(cpmeXp). The percent acid soluble product, X, was then 
calculated using the following expression: 
X — (cprrigxp/cpmcon ) x 100. 
RESULTS AND DISCUSSION 
Results 
Requirements for the Degradation of DNA by Daunomycin 
The antibiotic daunomycin, in the presence of a reducing agent, 
a copper salt, and molecular oxygen, causes the degradation of double- 
stranded DNA to acid-soluble products (Table 1). The degradation of 
DNA was also followed by monitoring the increase in the acid solubi¬ 
lized product as a function of time (Figure 3). The degradation 
appeared to be somewhat nonlinear with time. In all experiments 
where the metal ion was Cu(11)( 1 ym), the maximum acid soluble 
product was close to 50% but not higher than 60%. 
Chelex-treatment of all reagents to remove contaminating metals 
was done, as described under Materials and Methods, to demonstrate the 
requirement for Cu(II) in the complete reaction mixture. There was 
no appreciable amount of degradation observed in the absence of Cu(II) 
as indicated by the low percent (4%) acid soluble product (Table 1). 
Because metal ions are capable of complexing with daunomycinthe 
requirement for Cu(II) suggests that the degradation of DNA may be 
catalyzed by a daunomycin-Cu(II) complex. 
A reducing agent was required for the degradation of DNA, as was 
the case with 1,10-phenanthroline and its inhibition of nucleotide 
polymerization.^»^ Omission of the reducing agent from the clea- 
16 
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Table 1. Requirements for the Degradation of DNA 
components cpm average 
cpm 




minus Cu(II )l) 196 
260 209 4 
172 
minus 2-mercapto- 111 
ethanolb 100 102 2 
95 
minus daunomycind 115 
120 117 2 
117 
minus oxygenb»c 69 
89 76 <1 
73 
aThe complete reaction mixture contained in a final volume of 0.1 
ml 50mM Hepes, pH 7.4, 20 uM poly(dA-[^H]T), ImM 2-mercaptoethanol , 
1 MM CUSO4, and 50 uM daunomycin. After 30 min at 24°C, acid 
soluble radioactivity was determined. 
^The reaction mixture contained all components as in _a minus the 
component indicated. 
cThis experiment was carried out by bubbling N2 gas through the re¬ 
action mixture. 




Figure 3. Degradation of poly(dA-[^H]T) as a function of time in 
the presence of 50 uM daunomycin, 1 uM CUSO4, and 1 mM 2-mer- 
captoethanol. 
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vage assay yielded only 2% acid soluble product (Table 1). Since most 
DNA and RNA polymerases require added sulfhydryl compounds for acti¬ 
vity,^ we used a thiol reducing agent, 2-mercaptoethanol, to induce 
the degradation of DNA in the presence of daunomycin and Cu(II). 
In addition to the thiol and a copper salt, the degradation of 
DNA by daunomycin was also dependent upon the presence of molecular 
oxygen. The degradation of DNA was inhibited when the reaction was 
carried out by bubbling nitrogen through the reaction mixture. The 
requirement for a reducing agent (2-mercaptoethanol) and oxygen 
for the degradation of DNA suggests that a reduced form of oxygen 
may be the reactive species responsible for the degradation. 
These results appear credible since it is known that the 1,10- 
phenanthroline-Cu(II) complex can catalyze the air oxidation of sulf¬ 
hydryl groups in proteins^ as well as other sulfhydryl compounds;^ 
and the autooxidation of thiols is known to generate free radicals 
with oxygen serving as their precursor.31 The [^Hl-labeled products 
generated from the degradation of poly(dA-[^H]T) may suggest that 
the phosphodiester bond is the primary locus of attack on the DNA as 
observed for 1,10-phenanthrol ine by Marshall et_a1_.32 However, as has 
been reported, the thymine B-deoxyriboside bond or any other locus 
on the deoxyriboside can be the initial reaction site with phospho¬ 
diester backbone cleavage occuring rapidly thereafter.32 
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Effects of Metal Ions on the Degradation of DNA 
The ability of daunomycin-complexed metal ions to induce degra¬ 
dation is shown in Table 2. Downey and coworkers^ showed Cu(II) 
to be the only metal ion effective in degrading DNA by 1,10-phenan- 
throline. Unlike their report, other metal ions that are capable 
of forming complexes with daunomycin, i.e., zinc(II), magnesium(II ), 
calcium(II), and iron (II), etc., (Table 2) were effective in causing 
cleavage of DNA at concentrations equal to that of Cu(II). The 
amount of acid soluble product produced upon the degradation of poly- 
(dA-[^H]T) by these metal ion complexes was about 18% as compared to 
50% for the daunomycin-Cu(II ) complex. Table 3 shows the stability 
constants^ of metal-daunomycin complexes. Cupric ion has a higher 
stability constant compared to those of the other divalent metal ions, 
and will, therefore, show higher concentrations of daunomycin-Cu(II ) 
complex. In the cleavage reaction, only micromolar concentrations 
of the daunomycin-copper complex are required to induce degradation. 
Increasing the concentration of the other metal ions also increased 
the percent acid soluble product. At approximately 100-fold higher 
molar concentration over Cu(II), there was only a 2-fold increase in 
the cleavage of DNA by each metal ion. A sample calculation (for 
Mg(II)) of the concentrations of the complexes at the two concentra¬ 
tions employed (1 and 100 uM) gives .25 and 25 pM, using a stabil¬ 
ity constant of lO^*^. The observed 2-fold increase in the cleavage 
reaction is not, therefore, consistent with the 100-fold increase in 
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Table 2. Effect of Metal Ions on the Degradation of DNAa 
metal ion conc(uM) cpm average % acid solubleb 
cpm  
Zn(II) 1.0 945 
831 927 18 
940 
100 1273 
1251 1264 33 
1269 
Mg(11 ) 1.0 940 
937 931 18 
917 
100 1361 
1360 1337 35 
1290 
Fe(II) 1.0 983 
883 910 17 
895 
100 1077 
1074 1075 28 
1074 
Fe(III) 1.0 910 
909 906 17 
899 
100 1073 
1100 1081 28 
1070 
Ca(II) 1.0 902 
914 912 17 
920 
100 1413 
1423 1416 27 
1414 
Yb(111)c 1.0 1936 







Table 2. cont'd 
Cu(II) 1.0 2629 
2641 2633 51 
2630 
aPoly(dA-[^H]T) (20 yM) was cleaved in a reaction mixture con¬ 
taining 50mM Hepes, pH 7.4, ImM 2-mercaptoethanol, 50 yM daunomycin, 
and a given concentration of the metal ion. The acid soluble radio¬ 
activity was then determined after 30 min at 24°C. 
^The control cpm for the 1 yM concentrations (metal) was 5107 
and that for the 100 yM, 3728. 
cControl cpm: 5205. 
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TABLE 3. Stability Constant Logarithms of Metal-Daunomycin Complexes3»^ 
metal ion ]°g Km log 
H + 10.0 7.4 
Mg2+ 3.7 1.1 
Ca2+ 3.3 0.7 
Fe3+ 11.0 8.4 
Cu2+ 7.3 4.7 
Zn2+ 4.5 1.9 
Tb3+ 7.2 4.6 
Th^+ 10.3 7.7 
Yb3+ 5.6b 3.0 
aData is for a 1:2 (ML2) complex in aqueous solution at 20°C and 
0.15 M ionic strength. 
^Quoted from ref 46. 
cStabi1ity constant logarithms at pH 7.4 calculated using the re¬ 
lationship: Kp|_| = Km/ (1 + ([H 
+ ]/Ka) (see reference below). 
^Taken from Kiraly, R., 
1982, 67, 16. 
Martin, R. B. Inorganic Chimica Acta 
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the concentration of the complex that is expected to form. Since the 
extent of the cleavage appears to be about the same for all the metal 
ions, except Cu(II), this observation does not reflect the differences 
in the stability constants of the metal ions. 
The daunomycin-Yb(III) complex degraded DNA at about the same 
extent (54%) as the daunomycin-Cu(II ) complex (51%) when present in 
100-fold molar concentration. Similarly, despite the high affinity 
of Fe(III) (10^.4) for daunomycin, Fe(III) (1 uM) was not as effec¬ 
tive (17%) as Cu(II) in degrading DNA at pH 7.4 (Table 3). Martin 
and Kiraly33 have reported that the stability constants were pH de¬ 
pendent, and around neutral pH, Spiro et al34 observed that Fe(III) 
rapidly polymerizes. It can therefore be expected to be unavailable 
for daunomycin chelation. In order to get reproducible results in 
studies of this kind, Fe(III) must be chelated to be kept stable. In 
a previous report, Myers et al 35 used an acetohydroxamiciron complex 
as an effective donor to adriamycin. This allowed reproducible forma¬ 
tion of a stable drug-metal ion complex. Presumably this iron dona¬ 
tion works due to the large association constant of the adriamycin- 
Fe(III) complex (10^3) as compared to 10? for acetohydroxamic acid 
complex.35 in this study, the conditions used in the Fe(III) experi¬ 
ment would not therefore allow one to accurately assess its effects 
on the degradation of DNA. 
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Increasing concentration of Cu(II) has been shown to enhance the 
degradation of DNA by 1,10-phenanthroline.^ The optimal concentra¬ 
tion of Cu(11) reported in degrading DNA by 1,10-phenanthroline was 
2.5 yM yielding 95% acid soluble product. Figure 4 shows the 
effect of varying Cu(II) concentration on the degradation reaction. 
At Cu(II) concentration of as low as 1.0 uM, one can see approxi¬ 
mately 50% degradation. Although, the degradation appeared to in¬ 
crease with increasing Cu(II) concentration, these results must 
be interpreted with caution. During the course of this study, a 
red to purple precipitate was repeatedly observed when the Cu(II) 
concentration were higher than 2.5 yM. At lower Cu(II) concentra- 
ration no such precipitate was observed. These results are in 
agreement with those of Greenaway and Dabrowiak^ who used 
spectroscopic studies in aqueous solutions to show the Cu(II) 
(5 x 10"5 M) binding properties of daunomycin. At pH values between 
6-8.5, they observed the precipitation of a purple solid that was 
isolated from solution. The shift of the anthraquinone bands observed 
by these investigators in the visible absorption spectrum indicated 
that the Cu(II) is binding to the aglycone portion of daunomycin 
as seen with other hydroxyanthraquinones. 
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Concentration of Cu(II)(wM) 
Figure 4. Effects of micromolar levels of Cu(II) ions on the degra¬ 
dation of poly(dA-[^H]T) by daunomycin. 
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Effects of Superoxide Dismutase and Catalase on the Degradation of DNA 
The role of superoxide anion in the thiol catalyzed cleavage of 
DNA by the daunomycin-Cu(II) complex was examined by analyzing the 
effect of superoxide dismutase. Superoxide dismutase (SOD) slightly 
increased the DNA damage by the daunomycin-Cu(II) complex (58% acid 
soluble product, Table 4) compared to that in the absence of SOD. 
These results suggest that the conversion of superoxide anion to 
hydrogen peroxide by superoxide dismutase slightly increases the 
extent of the cleavage reaction by increasing the concentration of 
hydrogen peroxide. The results also eliminate the possibility of the 
superoxide anion being the primary reactive species, since it is 
converted to hydrogen peroxide by the enzyme, and hence unavailable 
to take part in the reaction. If the superoxide anion were the 
reactive species, one would expect an inhibitory effect by the enzyme 
rather than an increase or no effect in the cleavage. 
Evidence for excluding superoxide anion acting alone was also ob¬ 
served by Graham et_ al_37 when studying the superoxide anion formation 
in the oxidation of 1,10-phenanthroline-Cu(II ) complex. When 1,10- 
phenanthroline-Cu(II) complex was replaced by the cupric complexes of 
2,2'-bipyridine and 2,2',21'-terpyridine, both of which can produce 
diffusible superoxide anion in the presence of thiol and molecular 
oxygen, the complexes were not effective in cleaving DNA under aerobic 
conditions. Thus, Graham et al 37 have shown that the superoxide anion 
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Table 4. Effect of Superoxide Dismutase and Catalase on the Degra¬ 
dation of DNA by Daunomycin-Cu(II) Complex3 
conditions cpm average 
cpm 
% acid solubled 
completea 2222 
2202 2190 52 
2148 
plus catalase^ 140 
(10 ug/ml) 130 130 3 
122 
plus superoxide 2438 
dismutaseb 2470 2452 58 
(40 yg/ml) 2448 
plus boiled 1206 
catalaseb»c 1184 1230 29 
(10 yg/ml) 1300 
aPoly(dA-[^H]T) (20 uM) was cleaved in 0.1 ml solution con¬ 
taining 50mM Hepes, pH 7.4, ImM 2-mercaptoethanol, 50 yM daunomy- 
cin, 1.0 uM CUSO4. 
^Indicates the complete system plus the component indicated. 
cThe boiled catalase was prepared by heating the catalase for 10 
min before addition. 
^Control cpm: 4206 
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serves only as an intermediate in the generation of other reactive 
species and, therefore, can not be directly responsible for the clea¬ 
vage of DNA. 
Table 4 also shows the effects of catalase on the degradation of 
DNA by the daunomycin-Cu(II) complex. In this thiol requiring 
system, catalase was effective in inhibiting the degradation of DNA, 
suggesting that hydrogen peroxide was formed in situ and, most impor¬ 
tantly, was required for the degradation. The involvement of hydrogen 
peroxide in the reaction was further tested by using boiled (inacti¬ 
vated) catalase. The percent acid soluble product was found to be 
29% in this case as compared to 3% for active (not boiled) catalase. 
These results further suggest that the superoxide anion is not solely 
responsible for the cleavage. 
The degradation of DNA by daunomycin was also studied in the 
presence of a free radical-generating system, i.e., xanthine oxidase- 
hypoxanthine, in which the reduced products of oxygen, such as super- 
oxide anion, are known to be generated via the oxidation of hypoxan- 
xanthine oxidase 
02 + e"  — > 02
r (1) 
thine to xanthine (eq 1).^ As shown in Table 5, degradation studies 
in the presence of xanthine oxidase showed an absolute requirement 
for daunomycin, Cu(II), and hypoxanthine. The role of superoxide an¬ 
ion in the free radical generating system was examined using super- 
oxide dismutase. Superoxide dismutase inhibited the degradation of 
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Table 5. Degradation of DNA by Daunomycin in the Presence of Xan¬ 
thine Oxidase and Hypoxanthine 
conditions cpm average 
cpm 
% acid soluble0 
completea 3178 3178 59 
minus Cu(II)*3 42 42 <1 
41 
minus daunomycin*3 50 51 <1 
52 
minus hypoxanthine*5 46 46 <1 
46 
minus daunomycin 44 40 <1 
and hypoxanthine*5 36 
plus superoxide 758 773 14 
dismutase (40 ug/ml)*5 788 
plus catalase*3 139 134 3 
(10 ug/ml) 130 
aThe complete reaction mixture contained, in a final volume of 0.1 
ml, 50 uM daunomycin, 50mM Hepes, pH 7.4, 20 uM poly(dA-[^H]T), 
50 ug of xanthine oxidase, 0.1 mM hypoxanthine, and 2.5 tM CUSO4. 
Acid soluble radioactivity was determined after 30 min at 25°C. 
^The complete reaction mixture plus or minus the component indi¬ 
cated. 
cControl cpm: 5377. 
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daunomycin. The sensitivity of the hypoxanthine-xanthine oxidase 
to superoxide dismutase can be explained by the possible roles 
of superoxide anion in this system. Superoxide anion may be impor¬ 
tant in mediating the reduction of the daunomycin-Cu(II) complex to 
daunomycin-Cu(II) (eq 2), as observed by Valentine and Curtis-^ with 
Dm-Cu(II) + 02"  ^ 0 2 + Dm-Cu(I) (2) 
1,10-phenanthroline-Cu(II) complex. Another well known reaction in¬ 
volving superoxide anion is that in which it promotes an efficient 
catalasesensitive DNA cleavage (Table 5 shows that catalase was 
effective in inhibiting the degradation of DNA), because it increases 
the concentration of hydrogen peroxide via the one-electron transfer 
reactions summarized in eqns. 2 and 3, respectively.37,38 Superoxide 
C>2 * + 02 * + 2H
+ ■ — ■ ^ H202 + 02 (3) 
dismutase may inhibit this system by diverting most of the superoxide 
anion to hydrogen peroxide thus preventing the reduction of daunomy- 
cin-Cu(II) to daunomycin-Cu(I), although it could not be established 
that this was the role played by superoxide anion in the cleavage 
reaction from these results. However, this data does suggest that 
superoxide anion is an intermediate in the cleavage reaction. 
Synergistic Effect of Hydrogen Peroxide in the Cleavage of DNA. 
Catalase was effective in blocking the cleavage chemistry in both 
the thiol and the xanthine oxidase-hypoxanthine systems, indicating 
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that hydrogen peroxide must be involved in the cleavage. These re¬ 
sults prompted our investigation into the role of hydrogen peroxide 
(Table 6). Sufficiently high concentrations of hydrogen peroxide are 
known to reduce cupric to cuprous.^ Moreover, hydrogen peroxide may 
be formed under aerobic conditions by the oxidation of daunomycin- 
Cu(I) by molecular oxygen as observed with 1,10-phenanthroline by 
Crumbliss and Poulos (eq 4).40 Their results showed that the concen¬ 
tration of hydrogen peroxide formed under aerobic conditions could 
2H + + 02 + 2(Dm)2Cu(I)  » H202 + 2(Dm)2Cu(II) (4) 
not exceed 0.2 mM and involves a coordinated complex. 
Exogenously added hydrogen peroxide overwhelmingly enhanced the 
percent acid soluble product (Table 6) when added to the reaction 
mixture containing a thiol reducing agent capable of generating 
(Dm)2Cu(I) from (Dm)2Cu(Ilj. The addition of hydrogen peroxide 
increased the amount of percent acid soluble product from 54%, for 
the thiol only system, to 95% when hydrogen peroxide was present at 
the start of the reaction. 
The in situ generation of hydrogen peroxide explains the oxygen 
dependence of the cleavage of DNA, suggesting further the possibility 
that yet another reduced form of oxygen may also be responsible for the 
cleavage. The requirement of hydrogen peroxide for DNA degradation 
suggests the possibility that hydroxyl radical, a very potent oxidizing 
agent, which can be generated via the Haber-Weiss reaction^ of oxy¬ 
gen and hydrogen peroxide or from the reduction of hydrogen peroxide 
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Table 6. Synergistic Effect of Hydrogen Peroxide on Cleavage of DNA 
by Daunomycin 
conditions cpm average 
cpm 
% acid soluble15 
completea 2547 2547 54 
plus hydrogen 4674 4523 95 
peroxidec 4372 
aThe complete reaction mixture contained alternating copolymer 
poly(dA-[^H]T) (20 uM), 5mM HoC^, 1 uM CuSO^, 50 uM daunomycin, 
ImM 2-mercaptoethanol , and 50mM Hepes in a final volume of 0.1 ml. 
^Control cpm: 4757. 
cAs in _a plus hydrogen peroxide. 
34 
by chelated transition metals, may be another reactive species re¬ 
quired for the cleavage reaction. Table 7 shows the effect of the 
addition of sodium acetate and sodium benzoate to the thiol system. 
The second order rate constants for the reaction of a hydroxyl radi¬ 
cal with acetate and benzoate have been determined to be, 
respectively, 4.2 * 10^ and 3.3 x 10^ M^s"*.^2,43 Acetate and 
benzoate are, therefore, known scavengers of the hydroxyl radical. 
Benzoate and acetate were not, however, effective inhibitors of the 
cleavage reaction when present at a concentration of 50 yM, and 
caused only partial inhibition at higher concentrations (100 U“1). 
An equivalent concentration of sodium chloride was tested for its 
inhibitory effects and showed no effect on the degradation of DNA. 
The second order rate constant for the reaction of a hydroxyl radical 
with sodium chloride is about 10^.43 Therefore, one would expect to 
see inhibition by sodium chloride as well. Overall, the results 
strongly suggest that the hydroxyl radical is unlikely to be the 
primary reactive species in the cleavage reaction. 
The Effect of Ethidium Bromide on the Degradation 
The effects of various concentrations of ethidium bromide were 
examined to test whether increasing concentrations of ethidium bro¬ 
mide would interfere with the ability of the daunomycin-metal ion 
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Table 7. Effect of Various Hydroxyl Radical Scavengers on the Thiol - 
Dependent Daunomycin-Cu(II) Complex 
scavenger concn (mM) cpm average 
cpm 
% inhibition13 
acetate3 50 814 
830 821 18 
819 
100 1491 
1515 1505 33 
1509 
benzoate3 50 902 
909 912 20 
925 
100 2217 
2200 2189 48 
2150 
NaCl3 50 93 
84 91 2 
96 
100 90 
88 91 2 
95 
aThe complete reaction mixture contained, in a final volume of 0.1 
ml, 50 yM daunomycin, 50mM Hepes, pH 7.4, 20 yM poly(dA-[^H]T, 
plus the component indicated. 
^The percent inhibition is calculated by substracting the percent 
acid soluble from the complete system represented as 100%. 
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to induce cleavage of DNA (Table 8). The amount of acid soluble 
product decreased considerably as the concentration of ethidium bro¬ 
mide increased (OuM-lOOuM). A plot of the percent inhibition 
by ethidium bromide against the ratio of the concentration of ethi¬ 
dium bromide to that of daunomycin is shown in Figure 5. When the 
concentration ratio increased from 0.2 (10:50) to 1.0 (50:50), the 
percent inhibition rose from 9 to about 91%. 
Ethidium bromide interacts with double-stranded DNA by interca¬ 
lating between adjacent base pairs,^3 and when in the presence of a 
thiol, Cu(II), and molecular oxygen does not degrade DNA (Table 9). 
Thus, it is evident that ethidium bromide must compete for binding 
sites on poly(dA-T). 
An important observation that can be gleaned from the inhibition 
study is that when both drugs (at a ratio of 1:1) are added together 
in excess of the polymer, there are a limited number of binding sites 
on DNA for the drug molecule and thus the competition between ethi¬ 
dium bromide and daunomycin becomes more pronounced. However, for 
systems where daunomycin, Cu(II), and poly(dA-T) were equilibrated 
for 0, 20, and 40 min, before the addition of ethidium bromide, a re¬ 
verse effect was observed (Table 9). The amount of acid soluble pro¬ 
duct increased from 9% (in the system where the ratio of ethidium bro¬ 
mide to daunomycin was 1:1, no pre-equilibration) to 42% in the system 
which was pre-equi1ibrated for 40 min. The increased acid soluble 
product appears to suggest that ethidium bromide may initially occupy 
Table 8. Concentration Effect of Ethidium Bromide on the Degradation of DNA by Daunomycin3 
[EtBr], 
yM 





































272(219) 4 9 91 
100 2.0 
216(202) 
240(200) 246(195) 4 9 91 




















Figure 5: A plot of the percent inhibition against the ratio of ethidium bromide to daunomycin. 
The complete reaction mixture contained poly(dA-[^H]T) (20 IJM), daunomycin, and increasing con¬ 
centration of ethidium bromide (0 uM-100 uM). 
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Table 9. Post Effect of Ethidium Bromide After Equilibration of 






(1:2.5:2.5) (total 274 
equi 1. time = 0)*3 272 
[DNA]:[Dm]:[EtBr] 1560 
(1:2.5:2.5) (total 1638 
equil. time = 20)b 1624 
[DNA]:[Dm]:[EtBr] 2376 
(1:2.5:2.5)(total 2454 
equil. time = 40)*3 2460 
[DNA]:[Dm]:[EtBr] 2340 
(2:1:1) (total 2204 
equil. time = 0)c 2250 
[DNA]: [Dm]: [EtBr] 4480 
(2:1:1) (total 4610 
equil. time = 10)c 4686 
average 
cpm 
% acid % relative 
soluble0* acid soluble 
2716 47 100 
273 5 4 
1607 28 59 










aThe complete reaction mixture contained in a final volume of 
0.1 ml, 50 yM daunomycin, 50 yM Hepes, pH 7.4, 20 poly- 
(dA-[3H]T), and 1 mM 2-mercaptoethanol, 1 yM CuSO^. 
^Indicates complete system with concentration ratios of compo¬ 
nents and equilibration (equil.) times as indicated, control cpm: 
5828. 
indicates complete system with concentration ratios and equili¬ 
bration times in min as indicated, control cpm: 11920. 
^The complete system as in a_ but when heat denatured poly(dA-T) 
was used, the percent acid soluble product was 3%; the complete system 
as in a_ but daunomycin replaced by 50 yM ethidium bromide gave only 
3% acid soluble product. 
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or block reactive sites needed for daunomycin binding. However, 
after 40 min these sites are apparently occupied by danunomycin after 
displacement of intercalated ethidium bromide by daunomycin. 
The displacement of ethidium bromide by daunomycin is logical 
since daunomycin has a binding constant of 7.6 (+_ 0.6) x lO^M"! for 
its interaction with double-stranded poly(dA-T)44 while that of ethi¬ 
dium bromide is 2.9 x 10^.23 since the binding constant of daunomycin 
to poly(dA-T) is greater than that of ethidium bromide, there should 
not be any inhibition observed by ethidium bromide, if the reaction 
is controlled by the thermodynamics of binding. 
There is no known kinetic studies on the interaction of dauno¬ 
mycin with poly(dA-T). However, if one looks at the kinetics of bind¬ 
ing of daunomycin and ethidium bromide to calf thymus DNA, the rates 
for the two ligands are quite different. Chaires et al 45 have report¬ 
ed a three-step mechanism for the binding of daunomycin to DNA and 
obtained six rate constants (extracted from relaxation data) for this 
mechanism. The rate constants for the second step which represent 
the intercalation of the drug into the DNA helix (k2 = 92.5 s“* and 
k_2 = 11.25 s-1), are orders of magnitude slower than those reported by 
Bresloff and Crothers^ for ethidium bromide (k2 = 3.85 x 10^ 
M“*s“* and k_2 = 22.75“*). Thus, because of the difference in the ki¬ 
netics of binding, the sequence of addition of the two ligands should 
affect both the difference spectra and the extent of inhibition. 
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Figure 6 shows the difference spectra that were used to monitor 
the time dependence of the interaction of daunomycin with poly(dA-T) 
when ethidium bromide was present. The sample cuvette contained 
daunomycin and Cu(II) which were equilibrated for 2 min before addi¬ 
tion of poly(dA-T). Ethidium bromide, daunomycin, and Cu(II) were 
placed in the reference cuvette. Both cuvettes were allowed to 
equilibrate for 10 min, after which ethidium bromide and poly(dA-T) 
were added to the sample and reference cuvettes, respectively. 
Difference spectra were then taken after 0, 10, 20, 30, and 40 min. 
After the first 10 min, a substantial decrease in optical density 
(at 480 nm) was observed. The decrease continued until essentially 
no difference absorption was observed after approximately 40 min, 
indicating the presence of similar or identical species in both 
cuvettes. Moreover, the decrease observed at 480 nm must be due to 
intercalation, since external interactions are diffusion controlled 
and should not take 40 min to reach equilibrium. 
Ethidium bromide successfully competes with daunomycin for the 
limited number of binding sites on poly(dA-T). After ample time to 
reach equilibrium, daunomycin, because of its strong binding affinity 
for poly(dA-T), displaces intercalated ethidium bromide. If the 
number of binding sites is increased, for example one binding site 
per ligand molecule, then equilibration will not be as important. 
Degradation studies were performed for various equilibration times as 
in the difference absorption experiments as described earlier, where 
-P» 
GJ 
Figure 6. Difference spectra monitoring the equilibration of daunomycin with poly(dA-T). 
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the ratio of the concentration of DNA to ethidium to daunomycin was 
2:1:1 (Table 9). Slight excess poly(dA-T) was used to insure consid¬ 
erable intercalation of both ligands. The data obtained from these 
experiments indicated that even at zero equilibration time, dauno¬ 
mycin, because of its binding capacity, is able to intercalate and 
degrade DNA (19%). Moreover, when the two are allowed to equili¬ 
brate, the daunomycin slowly displaces the intercalated ethidium bro¬ 
mide. Thus, an increase in degradation is observed (Table 9). 
The interactions of daunomycin with double-stranded and heat 
denatured poly(dA-T) were compared to assess the degree to which the 
drug binding was dependent on the secondary structure of DNA since 
the ethidium bromide experiments suggested binding by an intercalative 
mode (Table 9). The poly(dA-T) is heterogenous in size containing 
hairpin turns and gaps even though it is expected to exist predominant¬ 
ly in a double-helical form.47 The amount of acid soluble product 
for the degradation of poly(dA-T) by daunomycin (47%) compared with 
the heat-denatured poly(dA-T) (3%), suggests a dependence on the sec¬ 
ondary structure of the DNA (for binding of daunomycin or the daunomy- 
cin-metal complex). Heat denatured poly(dA-T) may not have been 
degraded because the intercal ative complex was not able to form 
during the cleavage reaction. These findings are consistent with the 
importance of intercalation observed in the ethidium bromide studies. 
Discussion 
The anticancer drug, daunomycin, is known to cause DNA strand 
scission and to bind to DNA.48 The degradation of DNA by daunomycin 
requires a metal ion, a reducing agent (thiol), and molecular oxygen. 
The thiol used in this study was 2-mercaptoethanol. However, the 
free radical generating system, e.g., hypoxanthine-xanthine oxidase 
system, can substitute for 2-mercaptoethanol. The requirement for a 
thiol and molecular oxygen indicates the involvement of reduced forms 
of oxygen, such as superoxide anion and hydrogen peroxide in the de¬ 
gradation reaction. Our data apppears to suggest that an important 
feature of the cleavage reaction may be the binding of daunomycin via 
intercalation, although we did not establish if it is daunomycin or 
daunomycin-metal complex which is involved in the intercalation. 
Que et al49 have proposed two mechanisms responsible for the 
degradation of DNA by 1,10-phenanthroline-Cu(II ) (Scheme 1 and 2). 
Of all the metal ions which are able to form complexes with 1,10-phen- 
anthroline, i.e., cobalt, nickel, cadmium, or zinc, Cu(II) was the 
only metal found to be effective in degrading DNA. The resulting 
complex formed between the metal chelator and Cu(II) has been shown 
to act as a catalyst for the reduction of oxygen by a thiol, leading 
to the production of a very reactive species, the hydroxyl radical.49 
The first mechanism proposed involved the generation of hyroxyl 
radical by the 1,10-phenanthrol ine-Cu(I I ) complex [OP-Cu(II)] in the 
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presence of hypoxanthine-xanthine oxidase system (Scheme 1). Diffusi¬ 
ble superoxide anion is generated from the reduction of oxygen by 
xanthine oxidase via the oxidation of hypoxanthine to xanthine (eq 5). 
The superoxide anion generated is an important intermediate and, as 
depicted in Scheme 1, serves a dual role in both the formation of hy¬ 
drogen peroxide by spontaneous dismutation (eq 6) and the reduction 
of OP-Cu(II) to OP-Cu(I) (eq 7). The hydrogen peroxide generated in 
situ can then be reduced by OP-Cu(I) which leads to the regeneration 
of OP-Cu(II) and a hydroxyl radical (eq 8), Thus, OP-Cu(II) is be¬ 
lieve to act catalytical ly in the generation of hydroxyl radical 
which leads to strand scission. 
In constrast to the hypoxanthine-xanthine oxidase system, Scheme 
2 shows the second mechanism proposed by Que et al^ for the degra¬ 
dation of DNA in the presence of OP -Cu (II) and an organic reducing 
agent. In this system, the organic reducing agent (eq 10), rather 
than superoxide anion, reduces OP-Cu(II) to OP-Cu(I). Superoxide 
anion is produced by the reduction of oxygen by thiyl radical (eq 
11), and it is proposed that superoxide anion only serves for the 
production of hydrogen peroxide. Hydroxyl radical is generated 
the same as in Scheme 1 (eq 8) by the reduction of hydrogen per¬ 
oxide and and oxidation of OP-Cu(I) (eq 13). 
The proposed mechanisms for the degradation of DNA by 1,10- 
phenanthroline-cuprous complex have been demonstrated to be catalyzed 
by the transition metal, Cu(II). Unlike the Cu(II) specificity seen 
by Que et_ _al_,49 other metal ions that can form complexes with dauno- 
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Scheme 1. Proposed pathway for the generation of hydroxyl radicals 
by a 1,10-phenanthroline-Cu(II)complex in the presence of 
of xanthine oxidase and hypoxanthine.* 
xanthine oxidase 
°2 + e" > 02
r (5) 
202
r + 2H+__^ H202 + 02 (0) 
02
r + OP-Cu(II) —^ OP-Cu(I) + 02 (7) 
OP-Cu(I) + H202 —> OP-Cu(II) + *0H + OH” (8) 
•OH + DNA—> strand scission (9) 
*Taken from Que, B. G., Downey, K. M. and A. G. So, Biochemistry, 1980 
19, 5987. 
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Scheme 2. Proposed mechanism for the degradation of DNA in the pres¬ 
ence of OP-Cu(II) and an organic reducing agent.* 
HS-R-S- + OP-Cu(II) —» HS-R-S- + OP-Cu(I) 
HS-R-S* + 02—> S + H
+ + 02"* 
2O2"* + 2H+ —^ H202 
+ 02 
OP-Cu(I) + H202—» 'OH + OH + OP-Cu(II) 






♦Taken from B. G. Que, K. M. Downey, and A. G. So, Biochemistry, 1980, 
19, 5987. 
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mycin, such as Fe(II), Zn(II), Mg(II), and Ca(II), investigated in 
this work, can substitute for Cu(II) in degrading DNA. The electro- 
cnemical properties of these metal ions however do not allow them to 
be as easily oxidized or reduced as Cu(II).50 Thus, the mechanisms 
for the 1,10-phenanthroline-cuprous complex leading to the production 
of hydroxyl radical (subsequently used in strand scission), does not 
apply for the other metals based on their redox potentials.^ Simple 
binding of the metal ions to the polymer can not explain the data, 
because there is no reason why this should not be operative in the 
1,10-phenanthroline case. 
Current thought concerning a possible mechanism fo, the m^oe of 
action of daunomycin is focused on the redpx chemistry of th'.s an¬ 
thracycline. Most recently, K1 eyer et_ _al_51 have shown tnat anaerobic 
reduction of daunomycin yields 7-deoxydaunomycinone (II) v: two 
50 
sequential one electron reductions followed by elimination of daunos- 
amine to give a reactive species described as a semiquinone methide 
(III). The precise role of the interaction of this reactive interm¬ 
ediate with biological macromolecules (including DNA) is the focus of 
much current research; these include the inhibition of enzymes,52 the 
initiation of oxygen-dependent lipid peroxidation,53,54 and DN/\ degra¬ 
dation pathways.^ 
In providing a basis for rationalizing the data obtained in this 
thesis, we have proposed several mechanistic suggestions involving 
the redox potential of the thiol and metal ions, which cannot be 
readily oxidized or reduced but may only serve a catalytic role in 
the degradation of DNA. When the daunomycin metal complex is formed 
under experimental conditions, the quinone functional group of the 
anthracycline can accept either one or two electrons, provided an 
51 
electron source is available. Given the redox chemistry of the thiol 
and the stereochemistry of protonation, a thiol can denote electrons 
to daunomycin which then accepts a proton from the solvent (eq 15). 
In the presence of oxygen, the resulting reduced daunomycin (DmH2) (or 
7-deoxydaunomycinone) can generate the superoxide anion and peroxy 
Dm + 2H0-R-SH > DmH2 + 2H0-R-S* 
DmH2 + 02—> DmH* + H02* 
H02 * 02‘ + H
+ 
202





derivatives of organic compounds (eq 16 & 17). This sequence of 
steps is supported by the work of Lown and Sim^6 who have shown 
that 5,8-quinolinequinone readily accepts hydrogens from reduced 
pyridines, to form 5,8-dihydroxyquinone which will autooxidize as a 
metal complex to produce hydrogen peroxide and 5,8-quinolinequinone 
capable of inducing single strand breaks in PM2 ccc DNA (covalently 
closed circular DNA). 
Studies with reduced quinolinequinones have shown the importance 
of divalent metal ions complexed with these compounds. Cone et al^ 
have correlated the metal ion efficiency for hydrogen peroxide pro¬ 
duction via dismutation of the superoxide anion as an intermediate. 
Ferrous ion, of all the metal ions studied, was found to be the most 
powerful in stimulating hydrogen peroxide production, and thus showed 
a pronounced catalytic effect on the rate of PM2 strand scission. 
Unlike the role of Cu (II) in 1,10-phenanthrol i ne system, Cone et al^ 
52 
showed that Cu(II) with NADH did not cleave the DNA at significant 
rates. The metal ions in our study, that have low redox potentials, 
may play a kinetic (catalytic) role in the autooxidation of reduced 
daunomycin or 7-deoxydaunomycinone to daunomycin. 
Our studies have shown that the thiol-dependent degradation of 
DNA requires hydrogen peroxide as an intermediate, because addition 
of catalase effectively prevents DNA damage. Thus, the key aspect of 
the cleavage reaction appears to be the generation of hydrogen per¬ 
oxide. On the basis of the chemistry of hydrogen peroxide, two pos¬ 
sible reaction pathways can be envisioned for the thiol and hydrogen 
peroxide dependent cleavage. The first pathway could involve the 
formation of a penta-coordinated cuprous complex involving DNA, dau¬ 
nomycin, and copper with hydrogen peroxide serving as a ligand and 
then attacking the DNA by an intramolecular nucleophilic attack. 
Coordinated alcohols have been shown to react readily with esters and 
ATP by a similar mechanism.5? Another pathway may be that hydrogen 
peroxide reacts with intercalated daunomycin which may somehow cause 
cleavage of DNA. The formation of hydroxyl radical from Cu(II) and 
hydrogen peroxide (eq 18) proposed by Kobashi and Horecker,29 for the 
most part, has been demonstrated under nonphysiologic conditions. In 
this study, hydroxyl radical scavengers were not effective inhibitors 
Cu (I ) + H202 ) Cu (II ) + ’OH + OH" (18) 
of the degradation by daunomycin (Table 7). Since very high concen¬ 
trations were required even for partial inhibition, it cannot be 
53 
argued that hydroxyl radical is the primary reactive species respon¬ 
sible for degradation of DNA by daunomycin. 
As in the work reported by Kleyer et_ al_,daunomycin may yield 
the reactive species, the semiquinone methide. If intercalated in 
the vicinity of susceptible bonds, it may lead to efficient DNA de¬ 
gradation. At present, however, no data are available to document 
the semiquinone methide occurring in thiol catalyzed systems. Hydro¬ 
gen peroxide itself can oxidize metal complexes of daunomycin which, 
in turn, may be able to produce either hydroxyl radicals or the semi¬ 
quinone methide. These possibilities will have to be explored in the 
future. 
CONCLUSION 
Though not completely elucidated, the mode of action of the 
anthracycline antibiotics is related to their ability to bind to DNA 
and inhibit nucleic acid synthesis. As found in this study, it is 
possible for daunomycin to have two distinct mechanisms by which it 
can generate reactive species: the metal ion dependent mechanism or 
via a reaction between daunomycin semiquinone and a reducing agent. 
There are some contrasting differences between the two mechanisms. 
Reduction of daunomycin to the semiquinone in the presence of oxygen 
and a reducing agent has been characterized by the production of a 
range of reactive species, such as semiquinone methide, superoxide 
anion, hydrogen peroxide, and hydroxyl radical.12,20,50 However, as 
mentioned earlier, the direct enzyme-catalyzed reduction of these 
anthracyclines by reduced nicotinamide-adenine dinucleotide (NADH) is 
the focus of much current research as it pertains to macromolecules 
such as DNA. Moreover, while the daunomycin semiquinone radical, 
superoxide anion, and hydrogen peroxide may be sufficient for DNA 
degradation, it is very unlikely that hydroxyl radical is the only 
species directly responsible for DNA degradation. 
In contast to the daunomycin semiquinone mechanism, the met¬ 
al ion complexes of daunomycin are able to catalyze direct DNA degra¬ 
dation requiring hydrogen peroxide as an intermediate. The hydrogen 
peroxide can be generated by either hypoxanthine-xanthine oxidase sys- 
54 
55 
tem or via the thiol dependent reduction of oxygen. This mechanism 
has interesting implications. Daunomycin semiquinone formation and, 
thus, superoxide and hydrogen peroxide production can be catalyzed by 
multiple enzymes including xanthine oxidase, mitochondrial NADH de¬ 
hydrogenase, and other flavoprotein reductases. This daunomycin 
semiquinone formation can act as a source of hydrogen peroxide to the 
daunomycin-metal complex as seen by Cone et_ al_.^ In this sense, the 
two mechanisms would be expected to operate cooperatively in the 
degradation of DNA. 
While these mechanisms are only suggestive, it would be desirable 
to have a more direct test of the formation and action of the daunomy¬ 
cin metal complexes in vivo. Future work may involve the investiga¬ 
tion of the chemical and biological properties of the anthracycline 
antibiotics. Knowledge gained from such studies is undoubtedly im¬ 
portant for understanding the mode of action of the anthracyclines, 
as well as in developing a logical approach to studying the in vivo 
system. 
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